Yossef Av-Gay Ph.D

Yossef Av-Gay Ph.D General Information

Biography

Mr. Yossef Av-Gay was a Co-Founder and served as Board Member at Advanced Inhalation Therapies. He became chief scientific officer in 2012 and was appointed AIT's chairman from 2014 to 2015. He is engaged in translational research of bacterial pathogens aimed at antimicrobial drug development. Since 1997, Prof. Av-Gay has been on the Faculty of Medicine Division of Infectious Diseases at the University of British Columbia, where he teaches microbiology. He consults to several pharmaceutical and biotechnology companies and is a member of the scientific review panels of the Canadian Institute of Health Research (since 2010), the French Agence Nationale de la Rechereche (since 2008), Innovative Medicine Innovations, the U.S. National Institutes of Health (since 2010), the European Commission FP6, FP7 (since 2002), and Horizon 2020 (since 2014). Prof. Av-Gay holds a Ph.D. in molecular microbiology, an M.Sc. in microbiology, and a B.Sc., in biology, all from Tel Aviv University.